IL-17A is more highly expressed in severe asthma patients than in mild-to-moderate asthma patients and could be a driver of neutrophilic inflammation in the asthmatic airway (Moore et al., 2014; Al-Ramli et al., 2009). This evidence concerns the gene IL17A and asthma.